Thinking about a GLP-1 for weight loss
Personalized Nutrient Planning with PlexusDx The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
Notably, Nicolau et al 8 reported a significant PASI reduction from 10 to 5.1 and DLQI improvement from 12.7 to 6.4 in patients with obesity without diabetes treated with liraglutide
Further research using direct measures of food noise, longitudinal neuroimaging, and controlled behavioral studies is needed to clarify mechanisms and determine their broader relevance for health and self-regulation
Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, et al
Drugs that are considered appetite suppressants and that contain stimulants may commonly cause insomnia (trouble sleeping), constipation, headache or dry mouth